PT Meratus Jasa Prima Tbk (IDX:KARW)

Orchard Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	5.29	4.59	6.78	7.14	2.93	4.53
Revenue Growth (YoY)	8.72%	-32.34%	-4.97%	143.30%	-35.22%	32.61%
Cost of Revenue	4.33	3.53	4.23	4.15	3.43	3.37
Gross Profit	0.96	1.06	2.55	2.98	-0.5	1.16
Selling, General & Admin	0.58	0.63	0.82	1.04	1.04	0.86
Other Operating Expenses	-0.02	-0.01	-0.03	0.28	-1.16	0.09
Operating Expenses	0.65	0.7	0.88	1.39	-0.12	1.03
Operating Income	0.32	0.35	1.67	1.6	-0.37	0.13
Interest Expense	-0	-0	-0	-0	-0	-0
Interest & Investment Income	0.01	0.01	0.01	0.02	0.07	0.03
Currency Exchange Gain (Loss)	0.01	-0.09	0.05	-0.2	-0.01	-0.01
Other Non Operating Income (Expenses)	0.01	-	-	-	-	-
EBT Excluding Unusual Items	0.34	0.26	1.74	1.41	-0.32	0.14
Gain (Loss) on Sale of Assets	-0.04	-0.04	0	-	-	-
Pretax Income	0.3	0.22	1.74	1.41	-0.32	0.14
Income Tax Expense	0.13	0.15	0.53	0.46	0.27	0.07
Earnings From Continuing Operations	0.18	0.08	1.2	0.96	-0.59	0.07
Minority Interest in Earnings	-0	-0	-0	-0	0	-0
Net Income	0.18	0.08	1.2	0.96	-0.59	0.07
Net Income to Common	0.18	0.08	1.2	0.96	-0.59	0.07
Net Income Growth	-	-93.54%	25.77%	-	-	-
Shares Outstanding (Basic)	542	587	587	587	587	587
Shares Outstanding (Diluted)	542	587	587	587	587	587
EPS (Basic)	0.00	0.00	0.00	0.00	-0.00	0.00
EPS (Diluted)	0.00	0.00	0.00	0.00	-0.00	0.00
EPS Growth	-	-93.55%	25.75%	-	-	-
Free Cash Flow	0.64	1.12	2.81	3.34	0.89	1.54
Free Cash Flow Per Share	0.00	0.00	0.01	0.01	0.00	0.00
Gross Margin	18.22%	23.00%	37.64%	41.80%	-16.96%	25.57%
Operating Margin	5.99%	7.64%	24.67%	22.39%	-12.76%	2.77%
Profit Margin	3.36%	1.69%	17.71%	13.38%	-20.05%	1.53%
Free Cash Flow Margin	12.04%	24.36%	41.41%	46.75%	30.41%	33.91%
EBITDA	2.17	2.19	3.5	3.39	1.41	1.91
EBITDA Margin	40.97%	47.81%	51.58%	47.47%	48.01%	42.13%
D&A For EBITDA	1.85	1.84	1.83	1.79	1.78	1.78
EBIT	0.32	0.35	1.67	1.6	-0.37	0.13
EBIT Margin	5.99%	7.64%	24.67%	22.39%	-12.76%	2.77%
Effective Tax Rate	41.38%	65.39%	30.79%	32.31%	-	51.94%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.